Uncategorized

Leap Therapeutics, Inc. today reported financial results for the fourth quarter and year ended December 31, 2022.

Ryvu Therapeutics reported financial results for the fourth quarter and the full year ended December 31, 2022, and provided a corporate update.

Humacyte, Inc. today announced financial results for the fourth quarter and year ended December 31, 2022, and highlighted recent corporate accomplishments.

Allarity Therapeutics, Inc. announced that it intends to effect a reverse stock split of its common stock, at a ratio of 1 post split share for every 35 pre-split shares.

¿Está buscando los mejores servicios VPN para utilizar mientras esté en España en 2023? Con la creciente necesidad de asegurar las actividades en línea y proteger la información personal, las redes privadas virtuales (VPN) se han convertido en una herramient …

CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that will use the body’s immune system to fight cancer, reported that CEO Ryan Davies discussed the future of the cancer therapeutic industry with Dr. Looper, a life-long researcher in the chemistry field.

Evotec SE announced that the Company has received a US$ 6.6 m grant from The Bill & Melinda Gates Foundation for drug discovery in tuberculosis.

Royal Philips announced it has convened the Annual General Meeting of Shareholders 2023 and published the agenda with explanatory notes.

Incyte announced that the U.S. Food and Drug Administration has issued a complete response letter for ruxolitinib extended-release tablets, a JAK1/JAK2 inhibitor, for once-daily use in the treatment of certain types of myelofibrosis, polycythemia vera and graft-versus-host disease.

Brii Biosciences Limited, a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet needs, announced a corporate update and reported its annual results for the year ended December 31, 2022.